                Figure 4.  Immunohistochemical analysis of β4, ErbB-3, P-Akt, ERβ1 and ErbB-2 in 232 primary BC.A. Distribution (%) of the bio-pathological factors β4 integrin subunit, ErbB-3, P-Akt(ser473), ERβ1 and ErbB-2 in 232 TAM treated breast cancers. B. Representative immunohistochemically positive cases for β4, ErbB-3, P-Akt(ser473), ERβ1 and ErbB-2 protein detection and control tissue sections.

